Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RC001 in Dravet Syndrome
NCT07675746Phase 1Recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of RC001 in Dravet syndrome (2 cohorts), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Number of Participants With Treatment-Emergent Adverse Events, Number of Participants With Serious Adverse Events and 4 more. Started Dec 2025; status: recruiting.
02
Drugs
RC001
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT07675746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675746.